Ex-Novartis Oncology Leader Riva Takes On Challenge Of Transgene Turnaround
Can Its Oncolytic Virus And Therapeutic Vaccine Platforms Finally Come Good?
The concept of using viruses to stimulate an immune response to cancers has been around a long time, but has so far yielded no major successes. 
